ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 260

Use of Positron Emission Tomography for the Diagnosis of Aortitis. a Study of 170 Patients from a Single Center

Lucia C. Domínguez-Casas1, Javier Loricera1, Diana Prieto Peña1, Isabel Martínez-Rodríguez2, Jose Ignacio Banzo2, Monica Calderón Goercke1, Vanesa Calvo-Río1, Nuria Vegas-Revenga1, MC Gonzalez-Vela3, Jesus Gonzalez- Vela4, José Luis Martín-Varillas1, Belén Atienza-Mateo1, Jose L. Hernández5, Miguel Angel González-Gay1 and Ricardo Blanco1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 2Nuclear Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 3Pathology Anatomy, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 4Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 5Internal Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: positron emission tomography (PET) and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Aortitis is the inflammation of the aortic wall. This entity is often under-recognised because most of its manifestations are non-specific. PET/CT scan plays an important role in the diagnosis and management of aortitis; however this technique is expensive.

Our aim was to compare the baseline characteristics of patients with a suspicion of aortitis and positive results on PET/CT scan and those with a negative result in order to search for predictive factors that improve the clinical probability of diagnosis aortitis by this imaging technique.

Methods:

Retrospective study on 170 patients and PET/CT scans ordered by suspicion of aortitis from a referral center from January 2010 to December 2016. According to a pre-specified protocol, the baseline epidemiological and clinical variables of patients with positive and negative PET/CT scans results for aortitis were reviewed. Distributions of categorical variables were compared by the Pearson Chi2 or Fisher exact test. Quantitative variables were analyzing using the Student t test or Mann-Whitney U test as appropriate.

Results:

In 170 patients, PET/CT scans were performed due to clinical suspicion of aortitis, being positive in 93 (54.7%) cases. Patients (113W/57M) had a mean age of 67.7±13.1 years (range, 20-90 years). One patient was excluded because missing clinical or laboratory data.

The underlying conditions at the momento of orderinf the PET/CT scan were: giant cell arteritis (GCA) (n=28), spondiloarthropaties (n=7), conectivopaties (n=6), Takayasu arteritis (n=3), ulcerative colitis (n=3), other condition (n=11) The remaining 111 patiens dud not hace any underlying condition suggestive of aortitis.

Characteristics of patients with positive and negative PET/CT sacan were shown in the Table. Patients with GCA had a higher percentage of positive PET/CT scans, whereas the were negative more frequently in patients who did not have any conidition suggestive of underlying aortitis. Only inflammatory low back pain and polymyalgic syndrome were significantly more frequent in patients with positives PET/CT scans.

Conclusion:

In this study, we have found the presence of inflammatory low back pain and polymyalgic syndrome, especially in GCA patients, may have clinical relevance in ordering a PET/CT scan when aortitis was suspected.

TABLE

Positive PET

n= 92

Negative PET

n= 77

p

Age (years), mean±SD

67.4± 11.1

68.1±15.2

0.73

Age ≥ 70 years, n (%)

39 (41.9)

41 (53.2)

0.14

Sex (women), n (%)

62 (67.4)

54 (70.1)

0.63

Underlying condition

  • Giant cell arteritis, n (%)

24 (26.1)

4 (5.2)

0.0002

  • Takayasu arteritis, n (%)

3 (3.3)

0 (0)

0.31

  • Ulcerative colitis, n (%)

2 (2.2)

1 (1.3)

0.87

  • Conectivopaties, n (%)

3 (3.3)

3 (3.9)

0.86

  • Spondiloarthropaties, n (%)

3 (3.3)

4 (5.2)

0.79

  • None, n (%)

54 (58.7)

57 (74.0)

0.03

  • Other, n (%)

3 (3.3)

8 (10.4)

0.11

Symptoms at the time of requesting PET

  • Constitutional syndrome, n (%)

30 (32.6)

36 (46.8)

0.06

  • Fever, n (%)

18 (19.6)

15 (19.5)

0.98

  • Inflammatory low back pain, n (%)

30 (32.6)

14 (18.2)

0.03

  • Diffuse lower limbs pain, n (%)

42 (45.7)

28 (36.4)

0.22

  • Atypical polymyalgia rheumatica, n (%)

30 (53.6)

13 (38.2)

0.15

  • Headache, n (%)

18 (19.6)

9 (11.7)

0.16

  • Polymialgic syndrome, n (%)

56 (60.9)

34 (44.2)

0.03

Laboratory markers at the time of requesting PET

  • Anaemia, n (%)

18 (20.2)

22 (28.9)

0.19

  • ESR (mm/1ªh), mean±SD

43.3±34.3

43.5±31.1

0.72

  • CRP (mg/dl), median [IQR]

0.9 [0.3-2.6]

0.9 [0.3-2.5]

0.54

Treatment at the time of requesting PET

  • Patients with corticosteroids, n (%)

48 (51.6)

36 (46.8)

0.48

  • Dosage of prednisone (mg), median [IQR]

10 [5-15]

10 [7.5-15]

0.80

  • Patients with traditional immunosuppressants, n (%)

11 (12.0)

5 (6.5)

0.21



Disclosure: L. C. Domínguez-Casas, None; J. Loricera, None; D. Prieto Peña, None; I. Martínez-Rodríguez, None; J. I. Banzo, None; M. Calderón Goercke, None; V. Calvo-Río, None; N. Vegas-Revenga, None; M. Gonzalez-Vela, None; J. Gonzalez- Vela, None; J. L. Martín-Varillas, None; B. Atienza-Mateo, None; J. L. Hernández, None; M. A. González-Gay, None; R. Blanco, None.

To cite this abstract in AMA style:

Domínguez-Casas LC, Loricera J, Prieto Peña D, Martínez-Rodríguez I, Banzo JI, Calderón Goercke M, Calvo-Río V, Vegas-Revenga N, Gonzalez-Vela M, Gonzalez- Vela J, Martín-Varillas JL, Atienza-Mateo B, Hernández JL, González-Gay MA, Blanco R. Use of Positron Emission Tomography for the Diagnosis of Aortitis. a Study of 170 Patients from a Single Center [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/use-of-positron-emission-tomography-for-the-diagnosis-of-aortitis-a-study-of-170-patients-from-a-single-center/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-positron-emission-tomography-for-the-diagnosis-of-aortitis-a-study-of-170-patients-from-a-single-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology